| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Biotech Growth N V is a 10% Owner at BDTX. Recent filings cover 15 purchases and 7 sales. Those positions are worth an estimated $6.3M at current prices.
Our model assigns Biotech Growth N V a middling insider score of 53/100, based on 16 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -14.6%.
Biotech Growth N V's largest disclosed position is in BDTX as 10% Owner, worth about $6.3M. The recent filings there lean toward selling, a net 1,002,299 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2022 | BDTX Black Diamond Therapeutics, Inc. | 10% Owner | Buy | 252,556 | $3.48 | $879,817.22 | +6.8% | -14.9% | -56.7% |